Education
About Us
Working with TipRanks
Follow Us
Bio-Gene Technology Ltd. (AU:BGT)
ASX:BGT
Total Valuation
Bio-Gene Technology Ltd. has a market cap or net worth of AU$8.24M. The enterprise value is AU$2.54M.
Market CapAU$8.24M
Enterprise ValueAU$2.54M
Share Statistics
Bio-Gene Technology Ltd. has 305,061,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding305,061,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bio-Gene Technology Ltd.’s return on equity (ROE) is -1.59 and return on invested capital (ROIC) is -154.30%.
Return on Equity (ROE)-1.59
Return on Assets (ROA)-1.20
Return on Invested Capital (ROIC)-154.30%
Return on Capital Employed (ROCE)-1.87
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bio-Gene Technology Ltd. is ―. Bio-Gene Technology Ltd.’s PEG ratio is 0.21.
PE Ratio―
PS Ratio0.00
PB Ratio2.08
Price to Fair Value2.08
Price to FCF-1.33
Price to Operating Cash Flow-4.55
PEG Ratio0.21
Income Statement
In the last 12 months, Bio-Gene Technology Ltd. had revenue of 0.00 and earned -2.58M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit-245.78K
Operating Income-3.07M
Pretax Income-2.58M
Net Income-2.58M
EBITDA-2.58M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.71M and capital expenditures 0.00, giving a free cash flow of -1.71M billion.
Operating Cash Flow-1.71M
Free Cash Flow-1.71M
Free Cash Flow per Share>-0.01
Dividends & Yields
Bio-Gene Technology Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.22
52-Week Price Change-50.00%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)50.46
Average Volume (3m)988.87K
Important Dates
Bio-Gene Technology Ltd. upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 25, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Bio-Gene Technology Ltd. as a current ratio of 3.86, with Debt / Equity ratio of 3.15%
Current Ratio3.86
Quick Ratio3.86
Debt to Market Cap0.02
Net Debt to EBITDA0.42
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bio-Gene Technology Ltd. has paid -385.63K in taxes.
Income Tax-385.63K
Effective Tax Rate0.15
Enterprise Valuation
Bio-Gene Technology Ltd. EV to EBITDA ratio is -0.89, with an EV/FCF ratio of -0.90.
EV to Sales0.00
EV to EBITDA-0.89
EV to Free Cash Flow-0.90
EV to Operating Cash Flow-0.90
Balance Sheet
Bio-Gene Technology Ltd. has AU$1.14M in cash and marketable securities with AU$51.21K in debt, giving a net cash position of AU$1.09M billion.
Cash & Marketable SecuritiesAU$1.14M
Total DebtAU$51.21K
Net CashAU$1.09M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bio-Gene Technology Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―